Walk and Talk: A Randomized Controlled Trial of High Intensive 3MDR Treatment versus Care as Usual for Posttraumatic Stress Disorder.
Recruiting
- Conditions
- Posttraumatic Stress DisorderPTSD10002861
- Registration Number
- NL-OMON55588
- Lead Sponsor
- ARQ Nationaal Psychotrauma Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 134
Inclusion Criteria
- Patients with work-related Posttraumatic Stress Disorder
- 18 years or older
- Meet the DSM-5 criteria for Posttraumatic Stress Disorder
- Trauma-focused therapy naive
- Master the Dutch language
- Must be on a stable dose of medication at commencement of the trial for at
least four weeks, and will be asked to keep the dosage stable during the trail.
Exclusion Criteria
- Inability to walk
- Current severe alcohol or substance use disorder (SUD)
- Acute suicidality
- Acute psychosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary clinical outcome parameter is the difference in PTSD symptom<br /><br>severity measured prior to, during and after treatment. Furthermore,<br /><br>cost-effectiveness will be assessed through health-related quality of life and<br /><br>social costs. Our secondary outcomes include: avoidance behaviour, PTSD<br /><br>severity rated by a spouse, anxiety and depressive symptoms, impairment in<br /><br>daily functioning due to PTSD symptoms, neuropsychological functioning, and for<br /><br>the 3MDR condition physiological responses during sessions. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Our secondary outcomes include: avoidance behaviour, PTSD severity rated by a<br /><br>spouse, anxiety and depressive symptoms, impairment in daily functioning due to<br /><br>PTSD symptoms, neuropsychological functioning, and for the 3MDR condition<br /><br>physiological responses during sessions. </p><br>